πŸ‡ΊπŸ‡Έ FDA
Patent

US 10781255

Anti-CD83 antibodies and use thereof

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 10781255 (Anti-CD83 antibodies and use thereof) held by The Regents of the University of California expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/505, A61K2039/545, A61P, A61P37/06